How do the two active ingredients in Qtern work to lower blood glucose?

In Qtern, saxagliptin inhibits DPP-4, preventing incretin hormone breakdown and increasing glucose-dependent insulin secretion, while dapagliflozin inhibits SGLT2 in the kidneys, reducing glucose reabsorption and increasing glucose excretion in urine independently of insulin; both actions depend on blood glucose levels.